Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for TRIN and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for TRIN and 80,000+ other tickers.
See exactly how TRIN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TRIN and 80,000+ other tickers.
Trinity Capital Inc. is a business development company specializing in term loans, equipment financing, and private equity-related investments. The firm provides tech lending, equipment financing, life sciences, warehouse lending, and sponsor finance sources. The firm is industry agnostic and invests in growth-stage companies across industries, including aerospace, software, Agricultural Equipment, Alternative Protein, Clean Technology, Energy, Food and Beverage / CPG, Information Technology, Life Sciences, Oil and Gas, Robotics, Semiconductors, Transportation, and consumer and retail. They…
Income investors, who apply a buy-and-hold strategy, inevitably run into the problem of divergent yield on cost vs. actual portfolio yield. If the idea is to never sell and the portfolio has appreciated, then the key issue is that each reinvestment dollar generates less and less incremental income. Target yield instrument can be used to solve this issue.
Trinity Capital remains a "Buy" due to sustained outperformance versus major indices and a robust, well-managed 11.8% yield. TRIN's diversified BDC portfolio spans technology, equipment financing, and life sciences, supporting consistent investment growth and attractive distributions. Management issues shares at a premium to NAV, maintaining capital integrity and enabling sustainable, hefty payouts without eroding net asset value per share.
PHOENIX, July 14, 2026 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading international alternative asset manager, today announced that it plans to transfer the listing of its common stock to the New York Stock Exchange ("NYSE") and NYSE Texas from the Nasdaq Stock Market ("Nasdaq"). The Company expects to begin trading as a NYSE-listed company on or about July 27, 2026, maintaining the current ticker symbol "TRIN" for its common stock.
PHOENIX, July 9, 2026 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced a portfolio update for the second quarter and first half of 2026. Trinity Capital originated $709 million of new commitments in the second quarter of 2026, bringing new commitments for the first half of 2026 to $1.1 billion.
In the news release, Pearl Health Raises $110 Million to Expand Its AI Platform Helping Providers Deliver Better Outcomes at Lower Cost for Medicare Patients,